Hext Therapeutic Research Private Limited manufactures and exports WHO-GMP compliant pharmaceuticals engineered for efficacy, safety, and affordability — trusted by regulated markets, emerging economies, and government health systems.
Compliant Manufacturing
CoPP Capability for Export
Government Supplier
Quality Management System
Regulated & Emerging Markets
Plant Products
Hext Therapeutic Research Private Limited operates at the intersection of pharmaceutical science and public health access. India's pharmaceutical sector supplies approximately 20% of global generic medicine volume and 60% of global vaccine demand, built on a foundation of USFDA-recognized manufacturing infrastructure and WHO-GMP certification frameworks. Hext is built to operate within — and exceed — these standards, applying rigorous pharmacokinetic, pharmacodynamic, and quality-by-design principles to every formulation it develops.
Every product formulated under Pharmaceutical Quality Systems (PQS), Product Quality Review (PQR), and Quality Risk Management (QRM) principles aligned to Revised Schedule M and ALCOA+ data integrity standards.
Manufacturing infrastructure structured for WHO-GMP, USFDA, EU-GMP, and CDSCO simultaneous compliance, enabling parallel filings across regulated and emerging markets.
Cost-engineered formulations and government-supply-grade production lines designed to serve national health programs without compromising analytical rigor.
Pharmacokinetic/pharmacodynamic modeling and quality-by-design development.
Rigorous testing at every stage with full ALCOA+ traceability.
CoPP, NOC, CTD dossiers prepared to destination-market standards.
Scalable production and reliable supply chain management.
Whether you represent a regulated-market distributor, an emerging-market health ministry, or a government procurement agency — Hext Therapeutic Research Private Limited is ready to support your medicine supply needs.
